Goldman Sachs’s iShares US Medical Devices ETF IHI Stock Holding History

Goldman Sachs’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-327,400	Closed	-$17.2M	–	6070
2022 Q4	$17.2M	Buy	+327,400	New	+$16.6M	﹤0.01%	2093
2022 Q3	–	Sell	-225,000	Closed	-$11.3M	–	6399
2022 Q2	$11.3M	Buy	225,000 +203,900	+966%	+$11.1M	﹤0.01%	2397
2022 Q1	$1.29M	Buy	+21,100	New	+$1.26M	﹤0.01%	4626
2017 Q4	–	Sell	-27,600	Closed	-$768K	–	6492
2017 Q3	$768K	Hold	27,600	–	–	﹤0.01%	4797
2017 Q2	$766K	Buy	+27,600	New	+$731K	﹤0.01%	4711

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Goldman Sachs's IHI Position: Q2 2026 in Review

Goldman Sachs reduced its iShares US Medical Devices ETF (IHI) stake by 69% in Q2 2026, selling an estimated $62.4M and leaving 548,004 shares worth $27.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2361.

Goldman Sachs first reported a position in IHI in Q2 2013 and has held it in 53 quarters since. The position peaked at $118M in Q2 2019. 505 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Goldman Sachs held 548,004 shares of iShares US Medical Devices ETF worth $27.1M as of Q2 2026.
Goldman Sachs sold 1,229,792 iShares US Medical Devices ETF shares in Q2 2026, an estimated $62.4M.
iShares US Medical Devices ETF made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2361 holding.
Goldman Sachs first reported a position in iShares US Medical Devices ETF in Q2 2013 and has held it in 53 quarters since.
Goldman Sachs's iShares US Medical Devices ETF position peaked at $118M in Q2 2019.
505 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.